Appendiceal neuroendocrine tumour presenting as bilateral ovarian and breast metastasis
DOI:
https://doi.org/10.18203/2349-2902.isj20171484Keywords:
Appendiceal neuroendocrine tumour, Ovarian and breast metastasesAbstract
Neuroendocrine tumours (NETs) of the appendix (formerly known 'carcinoids') are rare and are usually detected incidentally after appendectomy. The reported frequency of metastases from appendiceal carcinoids is gradually increasing, may be due to the increased longevity of the patients with benign/malignant diseases. Here we report a case of NET of appendix in an 80 year old female who presented with bilateral ovarian mass, and later developed metastasis in the breast. Though uncommon, NETs producing bilateral ovarian metastasis is well described in literature, the commonest primary being ileum. Only few cases of neuroendocrine tumor metastasis to breast have been reported in the literature, but none from appendix as primary.
Metrics
References
Richter-Ehrenstein C, Arndt J, Buckendahl AC, Eucker J, Weichert W, Kasajima A, et al. Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? Breast Cancer Research and Treatment. 2010;124(2):413-7.
García-Carbonero R, Capdevila J, Crespo-Herrero G, Díaz-Pérez JA, Del Prado MMP, Orduña AV, et al. Incidence, patterns of care and prognostic factors for outcome of gastro enteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol. 2010;21:1794-803.
Pape UF, Berndt U, Müller-Nordhorn J, Böhmig M, Roll S, Koch M, et al. Prognostic factors of long-term outcome in gastro enteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2008;15:1083-97.
Deborah D, Corben AD, Catalan JP. Non-mammary metastases to the breast and axilla: a study of 85 cases. Mod Pathol. 2013;26:343-9.
Georgiannos SN, Chin J, Goode AW. Secondary neoplasms of the breast: a survey of the 20th Century. Cancer. 2001;92:2259-66.
Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, et al. Metastases to the breast from non-breast solid neoplasms. Cancer. 2007;110(4):731-7.
Dietel M, Beyer B, Thomas A, Dankof A, Winzer KJ, Kristiansen G, et al. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer. Histol Histopathol. 2007;22(11):1221-30.
Modlin IM, Shapiro MD, Kidd M. Oberndorfer S. origins and perspectives of carcinoid tumors. Hum Pathol. 2004;35(12):1440-51.
Kojima M, Ikeda K, Saito N, Sakuyama N, Koushi K, Kawano S, et al. Neuroendocrine tumors of the large intestine: clinicopathological features and predictive factors of lymph node metastasis. Frontiers Oncol. 2016;6:173.
Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813-29.
Warkel RL, Cooper PH, Helwig EB. Adenocarcinoid, a mucin‐producing carcinoid tumor of the appendix. A study of 39 cases. Cancer. 1978;42(6):2781-93.
Mosunjac MB, Kochhar R, Mosunjac MI, Lau SK. Primary small bowel carcinoid tumor with bilateral breast metastases: report of 2 cases with different clinical presentations. Arch Pathol Lab Med. 2004;128(3):292-7.
Harrist TJ, Kalisher L. Breast metastasis: an unusual manifestation of a malignant carcinoid tumor. Cancer. 1977;40(6):3102-6.
Mohanty SK, Kim SA, DeLair DF, Bose S, Laury AR, Chopra S, et al. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Modern Pathol. 2016;29(8):788-98.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934-59.
Amichetti M, Perani B, Boi S. Metastases to the breast from extramammary malignancies. Oncology. 1990;47(3):257-60.
Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. World Health Organization; 2010.
Rabban JT, Lerwill MF, McCluggage WG, Grenert JP, Zaloudek CJ. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Int J Gynecol Pathol. 2009;28(1):41-8.
Desouki MM, Lioyd J, Xu H, Cao D, Barner R, Zhao C. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Hum Pathol. 2013;44(11):2536-41.
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26(18):3063-72.
Coan KE, Gray RJ, Schlinkert RT, Pockaj BA, Wasif N. Metastatic carcinoid tumors- are we making the cut? American J Surg. 2013;205(6):642-6.
Downloads
Published
How to Cite
Issue
Section
